-
Mashup Score: 0Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance - 3 month(s) ago
Leukemia – Identification of novel loci for multiple myeloma when comparing with its precursor condition monoclonal gammopathy of unknown significance
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma - 3 month(s) ago
Leukemia – Cellular dynamics following CAR T cell therapy are associated with response and toxicity in relapsed/refractory myeloma
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification - 3 month(s) ago
Leukemia – Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 13Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens - 3 month(s) ago
Leukemia – Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses - Leukemia - 3 month(s) ago
Subtyping of acute myeloid leukaemia (AML) is predominantly based on recurrent genetic abnormalities, but recent literature indicates that transcriptomic phenotyping holds immense potential to further refine AML classification. Here we integrated five AML transcriptomic datasets with corresponding genetic information to provide an overview (n = 1224) of the transcriptomic AML landscape. Consensus…
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
Leukemia – The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5
Leukemia – Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 10Classification and nomenclature of hematologic diseases - 4 month(s) ago
The World Health Organization (WHO) Classification of Tumours provides a definitive classification of all tumours, worldwide. This is essential to underpin …
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 27
Myeloproliferative neoplasms (MPNs) are a group of chronic hematologic malignancies that lead to morbidity and early mortality due to thrombotic complications and progression to acute leukemia. Clinical and mutational risk factors have been demonstrated to predict outcomes in patients with MPNs and are used commonly to guide therapeutic decisions, including allogenic stem cell transplant, in…
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial - 4 month(s) ago
Leukemia – Determinants of lenalidomide response with or without erythropoiesis-stimulating agents in myelodysplastic syndromes: the HOVON89 trial
Source: www.nature.comCategories: General Medicine News, Onc News and JournalsTweet
Identification of novel loci for myeloma versus MGUS. https://t.co/1aPkgvLZvv